Microsoft and other tech firms sound alarm over coronavirus impact
Illustration: Aïda Amer/Axios
More companies are saying publicly that disruptions caused by the coronavirus are hitting their bottom lines. Microsoft warned Wednesday that its personal computing unit, which includes Windows and Surface, will likely miss revenue expectations due to a slower-than-expected return to production after the Lunar New Year.
The big picture: Although Apple was the first big tech company to warn of a financial impact from the outbreak, most industry watchers said they expected the impact to be felt broadly across the industry, which depends heavily on China for manufacturing.
In addition to Microsoft and Apple, chipmaker Nvidia has lowered its revenue expectations by $100 million for the current quarter.
- Shares of Nutanix fell more than 20% on Wednesday after the cloud storage company lowered its outlook for the year, blaming the virus.
Meanwhile: Global electronics manufacturing association IPC warned this week that the virus could cause suppliers to delay product shipments by roughly five weeks, based on a survey it conducted.
- The group said that most suppliers are quoting a three-week delay, on average, but the manufacturers expect the real delays will average closer to five weeks.
Our thought bubble: It was always clear that not just Apple, but any company that gets manufacturing done in China, would be affected by the crisis. The question remained whether we'd see just a couple of weeks' impact or a sharper and longer-lasting disruption. We still don't know the answer, but a more serious scenario looks more possible as the virus continues to spread, not just in China but beyond.
Yes, but: A small number of tech companies, those who focus on tech that helps employees work remotely, are seeing an uptick in business. Videoconferencing supplier Zoom, for example, has reportedly added as many users this year as for all of 2019.
Also: IBM is announcing today that its IBM Clinical Development (ICD) system will be available without charge to national health agencies for clinical trials designed to speed development of drugs to combat the virus. The company first offered the software to Chinese health officials last week and will offer it to a broader network of national health agencies.